Assertio Holdings Inc (ASRT)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$23.500.00%
Close 2026-06-17 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · ASRT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 102.2 | 118.7 | 125.0 | 152.1 | 156.2 | 111.0 | 106.3 |
| Cost of Revenues | — | — | — | — | — | 15.8 | 19.9 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 66.5 | 69.0 | 75.1 | 78.6 | 46.8 | 52.6 | 104.3 |
| R&D Expenses | 1.7 | 1.7 | 3.8 | 2.8 | 0.0 | — | — |
| Operating Income | (26.8) | (21.5) | (24.5) | (243.5) | 39.4 | 9.4 | (82.2) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 3.1 | — | — | 8.0 | 10.2 | 15.9 |
| Interest & Investment Income | 2.4 | 2.7 | 3.2 | 2.4 | — | — | — |
| Other Non-Operating Income / Expenses | (8.7) | (8.4) | 2.9 | (10.5) | (8.2) | (10.0) | 36.6 |
| EBT, Incl. Unusual Items | (35.5) | (29.9) | (21.5) | (254.1) | 31.2 | (0.6) | (45.5) |
| Income Tax Expense | 0.2 | 0.4 | 0.1 | 77.9 | (78.5) | 0.7 | (17.4) |
| Net Income | |||||||
| Net Income | (35.7) | (30.4) | (21.6) | (331.9) | 109.6 | (1.3) | (28.1) |
| Per Share | |||||||
| Basic EPS | (5.55) | (4.74) | (0.23) | (4.67) | 2.33 | (0.03) | (1.07) |
| Diluted EPS | (5.55) | (4.74) | (0.23) | (4.67) | 2.03 | (0.03) | (1.07) |
| Revenue per Share | 15.88 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.4 | 6.4 | 95.3 | 71.0 | 47.0 | 43.2 | 26.2 |
| Diluted Weighted Avg Shares | 6.4 | 6.4 | 95.3 | 71.0 | 54.7 | 43.2 | 26.2 |
| Supplemental | |||||||
| EBITDA | — | 8.5 | 1.4 | (215.3) | 72.8 | 38.5 | (55.7) |
| EBIT | (26.8) | (21.5) | (24.5) | (243.5) | 39.4 | 9.4 | (82.2) |
| Effective Tax Rate | -0.7% | — | — | -30.7% | -251.7% | -131.6% | 38.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.